Berkley Renewables Inc. Stock

Equities

BKS

CA0844941033

Oil & Gas Exploration and Production

Market Closed - Canadian Securities Exchange 09:30:00 2019-04-10 am EDT 5-day change 1st Jan Change
0.04 CAD +14.29% Intraday chart for Berkley Renewables Inc. -.--% -.--%
Sales 2016 1.03M 757K Sales 2017 1.72M 1.26M Capitalization 729K 534K
Net income 2016 - 0 Net income 2017 - 0 EV / Sales 2016 3.53 x
Net Debt 2016 2.92M 2.14M Net Debt 2017 4.76M 3.49M EV / Sales 2017 3.18 x
P/E ratio 2016
4.22 x
P/E ratio 2017
-1.16 x
Employees -
Yield 2016 *
-
Yield 2017
-
Free-Float 90.7%
More Fundamentals * Assessed data
Dynamic Chart
5 years
0.04
Extreme 0.04
0.04
10 years
0.01
Extreme 0.005
0.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 02-06-19
Director/Board Member 62 04-07-28
Members of the board TitleAgeSince
Director/Board Member 62 04-07-28
Chief Executive Officer 61 02-06-19
Director/Board Member 64 06-08-16
More insiders
Berkley Renewables Inc. is a Canada-based growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. (RepliCel). RepliCel's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. RepliCel is also developing an injection device (RCI) for optimal clinical delivery. It is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Calendar
More about the company